Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.32
-7.2%
$2.51
$2.07
$3.80
$71.07M0.5939,673 shs126,385 shs
Nyxoah S.A. stock logo
NYXH
Nyxoah
$7.54
-0.3%
$6.75
$5.55
$11.87
$256.81M1.6575,684 shs16,252 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$28.81
+0.4%
$30.43
$25.86
$39.08
$256.06M1.3527,075 shs55,067 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.10
-1.9%
$9.09
$8.15
$22.40
$253.41M2.1208,426 shs110,145 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
-7.20%-7.20%-1.69%-17.14%-11.79%
Nyxoah S.A. stock logo
NYXH
Nyxoah
-0.26%-1.69%+24.42%-28.26%-7.94%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
+0.42%-2.31%-7.96%-11.05%-7.87%
ZimVie Inc. stock logo
ZIMV
ZimVie
-1.94%-2.99%+4.36%-24.42%-45.18%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InspireMD, Inc. stock logo
NSPR
InspireMD
2.4798 of 5 stars
3.52.00.00.02.12.50.6
Nyxoah S.A. stock logo
NYXH
Nyxoah
2.2661 of 5 stars
3.53.00.00.02.10.80.6
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.9516 of 5 stars
3.51.00.00.02.11.70.6
ZimVie Inc. stock logo
ZIMV
ZimVie
3.2384 of 5 stars
3.35.00.00.03.11.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5093.97% Upside
Nyxoah S.A. stock logo
NYXH
Nyxoah
3.00
Buy$14.5092.31% Upside
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$49.5071.82% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3379.49% Upside

Current Analyst Ratings Breakdown

Latest NSPR, NYXH, ZIMV, and SMTI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$51.00 ➝ $53.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/21/2025
Nyxoah S.A. stock logo
NYXH
Nyxoah
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $14.00
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/8/2025
Nyxoah S.A. stock logo
NYXH
Nyxoah
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
3/26/2025
Nyxoah S.A. stock logo
NYXH
Nyxoah
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$46.00 ➝ $46.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $51.00
(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M10.11N/AN/A$1.83 per share1.27
Nyxoah S.A. stock logo
NYXH
Nyxoah
$4.36M58.85N/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$91.57M2.80N/AN/A$5.22 per share5.52
ZimVie Inc. stock logo
ZIMV
ZimVie
$443.55M0.57$3.29 per share2.77$15.43 per share0.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Nyxoah S.A. stock logo
NYXH
Nyxoah
-$46.77M-$2.13N/AN/AN/A-1,043.93%-51.68%-40.11%8/5/2025 (Estimated)
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$1.34N/AN/AN/A-10.71%-19.86%-10.91%8/11/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.71N/AN/A-77.31%2.90%1.17%8/7/2025 (Estimated)

Latest NSPR, NYXH, ZIMV, and SMTI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Nyxoah S.A. stock logo
NYXH
Nyxoah
-$0.49-$0.63-$0.14-$0.63$1.64 million$1.12 million
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
3/25/2025Q4 2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.19-$0.18+$0.01-$0.18$22.75 million$26.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Nyxoah S.A. stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Nyxoah S.A. stock logo
NYXH
Nyxoah
0.21
5.28
4.95
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.76
2.23
2.02
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38

Institutional Ownership

CompanyInstitutional Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Nyxoah S.A. stock logo
NYXH
Nyxoah
N/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Nyxoah S.A. stock logo
NYXH
Nyxoah
17.11%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
42.60%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Nyxoah S.A. stock logo
NYXH
Nyxoah
11034.06 million28.23 millionNot Optionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million4.01 millionNot Optionable
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.85 million26.77 millionOptionable

Recent News About These Companies

ZimVie: Screening Cheap (Rating Upgrade)
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

InspireMD stock logo

InspireMD NYSE:NSPR

$2.32 -0.18 (-7.20%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$2.41 +0.09 (+3.88%)
As of 06/13/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$7.54 -0.02 (-0.26%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$7.63 +0.09 (+1.18%)
As of 06/13/2025 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$28.81 +0.12 (+0.42%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$29.25 +0.44 (+1.54%)
As of 06/13/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.10 -0.18 (-1.94%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$9.10 +0.01 (+0.05%)
As of 06/13/2025 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.